Geneos Wealth Management’s Horizon Technology Finance HRZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-52
Closed -$628 2117
2023
Q2
$628 Hold
52
﹤0.01% 2052
2023
Q1
$587 Hold
52
﹤0.01% 2035
2022
Q4
$603 Hold
52
﹤0.01% 2009
2022
Q3
$0 Sell
52
-1,460
-97% -$18K ﹤0.01% 2272
2022
Q2
$17K Sell
1,512
-75
-5% -$940 ﹤0.01% 1750
2022
Q1
$22K Buy
1,587
+75
+5% +$1.13K ﹤0.01% 1756
2021
Q4
$24K Hold
1,512
﹤0.01% 1791
2021
Q3
$24K Buy
1,512
+52
+4% +$886 ﹤0.01% 1822
2021
Q2
$25K Hold
1,460
﹤0.01% 1798
2021
Q1
$24K Buy
1,460
+575
+65% +$8K ﹤0.01% 1978
2020
Q4
$12K Hold
885
﹤0.01% 2144
2020
Q3
$10K Hold
885
﹤0.01% 1942
2020
Q2
$9K Hold
885
﹤0.01% 1946
2020
Q1
$8K Sell
885
-1,175
-57% -$13.8K ﹤0.01% 1887
2019
Q4
$25K Hold
2,060
﹤0.01% 1586
2019
Q3
$24K Hold
2,060
﹤0.01% 1520
2019
Q2
$24K Hold
2,060
﹤0.01% 1547
2019
Q1
$24K Buy
+2,060
New +$25.2K ﹤0.01% 1484

Other funds holding HRZN

Geneos Wealth Management's HRZN Position: Q3 2023 in Review

Geneos Wealth Management sold out of Horizon Technology Finance (HRZN) in Q3 2023, closing a stake of 52 shares — an estimated $628 sold.

Geneos Wealth Management first reported a position in HRZN in Q1 2019 and held it in 18 quarters. The position peaked at $25K in Q2 2021. 46 funds tracked by Wall St. Rank hold HRZN as of Q3 2023.

  • Geneos Wealth Management reported no remaining Horizon Technology Finance position as of Q3 2023 after selling out during the quarter.
  • Geneos Wealth Management sold 52 Horizon Technology Finance shares in Q3 2023, an estimated $628.
  • Geneos Wealth Management first reported a position in Horizon Technology Finance in Q1 2019 and held it in 18 quarters.
  • Geneos Wealth Management's Horizon Technology Finance position peaked at $25K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Horizon Technology Finance as of Q3 2023.

Based on Geneos Wealth Management's 13F filing for Q3 2023, filed 11 Oct 2023.